Aliases & Classifications for Pityriasis Rosea

About this section

Aliases & Descriptions for Pityriasis Rosea:

Name: Pityriasis Rosea 10 12 36 65
 
Pityriasis Circinata 10

Classifications:



External Ids:

Disease Ontology10 DOID:8892
ICD1027 L42
ICD9CM29 696.3
SNOMED-CT59 156373006, 77252004
MeSH36 D017515
NCIt42 C26855
UMLS65 C0032026

Summaries for Pityriasis Rosea

About this section
Wikipedia:68 Pityriasis rosea (also known as pityriasis rosea Gibert) is a skin rash. It is benign but may inflict... more...

MalaCards based summary: Pityriasis Rosea, also known as pityriasis circinata, is related to human herpesvirus 8 and rheumatoid arthritis. An important gene associated with Pityriasis Rosea is HLA-C (Major Histocompatibility Complex, Class I, C), and among its related pathways are Immune response IFN alpha/beta signaling pathway and Antigen Presentation- Folding, assembly and peptide loading of class I MHC. The drugs methdilazine and methdilazine hydrochloride have been mentioned in the context of this disorder. Affiliated tissues include skin, heart and prostate.

Related Diseases for Pityriasis Rosea

About this section

Diseases related to Pityriasis Rosea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 145)
idRelated DiseaseScoreTop Affiliating Genes
1human herpesvirus 829.7HLA-A, HLA-B, HLA-C
2rheumatoid arthritis29.0HLA-B, HLA-DQB1, HLA-DRB1, HLA-DRB5
3psoriasis27.1HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
4pityriasis rotunda10.8
5lichen planus pemphigoides10.4HLA-DQB1, HLA-DRB1
6tucker syndrome10.4HLA-DQB1, HLA-DRB1
7heavy chain deposition disease10.4HLA-DQB1, HLA-DRB1
8pulmonary coin lesion10.4HLA-DQB1, HLA-DRB1
9hemorrhagic fever with renal syndrome10.4HLA-C, HLA-DRB1
10autoimmune polyglandular syndrome type 210.4HLA-DQB1, HLA-DRB1
11drug-induced mental disorder10.4HLA-C, HLA-DRB1
12best1 retinopathy10.4HLA-DQB1, HLA-DRB1
13non-distal monosomy 10q10.4HLA-DQB1, HLA-DRB1
14lichtenstein syndrome10.4HLA-DQB1, HLA-DRB1
15red cell phospholipid defect with hemolysis10.4HLA-DQB1, HLA-DRB1
16actinomycosis10.3HLA-DQB1, HLA-DRB1
17microsomia hemifacial radial defects10.3HLA-B, HLA-DRB1
18finnish upper limb-onset distal myopathy10.3HLA-DQB1, HLA-DRB1
19hypersensitivity reaction type ii disease10.3HLA-C, HLA-DRB1
20nut allergy10.3HLA-DQB1, HLA-DRB1
21moderately severe hemophilia a10.3HLA-DQB1, HLA-DRB1
22dermatitis10.3
23hypertonia10.3HLA-DQB1, HLA-DRB1
24bipolar ll disorder10.3HLA-DQB1, HLA-DRB1
25hypercementosis10.3HLA-B, HLA-DRB1
26periventricular leukomalacia10.3HLA-A, HLA-B
27bubonic plague10.3HLA-DQB1, HLA-DRB1
28hydromyelia10.2HLA-A, HLA-B
29bk-virus nephropathy10.2HLA-A, HLA-C
30retinitis10.2HLA-A, HLA-B
31suppurative cholangitis10.2HLA-B, HLA-DQB1
32anthracosis10.2HLA-A, HLA-B
33byssinosis10.2HLA-DQB1, HLA-DRB1
34inflammatory leiomyosarcoma10.2HLA-DRB1, HLA-DRB5
35undetermined early-onset epileptic encephalopathy10.2HLA-A, HLA-B
36hepatitis10.2
37lichen planus10.2
38prostate malignant phyllodes tumor10.2HLA-A, HLA-B
39acquired thrombocytopenia10.2HLA-A, HLA-B
40rectal disease10.2HLA-DQB1, HLA-DRB1
41gonococcal iridocyclitis10.2HLA-A, HLA-B
42estrogen excess10.2HLA-A, HLA-B
43malignant hypertension10.2HLA-A, HLA-B
44cholera10.2HLA-B, HLA-DRB1
45juvenile pilocytic astrocytoma10.2HLA-A, HLA-B
46exanthem10.1
47syphilis10.1
48influenza10.1
49herpes zoster10.1
50gianotti crosti syndrome10.1

Graphical network of the top 20 diseases related to Pityriasis Rosea:



Diseases related to pityriasis rosea

Symptoms for Pityriasis Rosea

About this section

Drugs & Therapeutics for Pityriasis Rosea

About this section

Drugs for Pityriasis Rosea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 15)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Tacrolimusapproved, investigationalPhase 41023104987-11-3445643, 439492, 445647
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
8-DEETHYL-8-[but-3-enyl]-ascomycin
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
FR900506
 
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
Hecoria
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus Hydrate
Tacrolimus anhydrous
Tacrolimus hydrate
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
2
Calcitriolapproved, nutraceuticalPhase 416132222-06-3134070, 5280453
Synonyms:
(1R,3S)-5-{2-[(1R,3aS,7aR)-1-((R)-5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol
(1S,3R,5Z,7e)-9,10-Secocholesta-5,7,10-triene-1,3,25-triol
(1alpha,3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(1alpha,3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trienetriol
(5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1-alpha,3-beta,25-triol
(5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,25-triol
(5Z,7e)-(1S,3R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol
1 alpha,25-Dihydroxyvitamin D3
1,25 (OH)2 D3
1,25 Dihydroxycholecalciferol
1,25(OH)2-20epi-D3
1,25(OH)2D3 & CD4
1,25(OH2)D3
1,25-(OH)2-D3
1,25-(OH)2D3
1,25-DHCC
1,25-DIHYDROXYCHOLECALCIFEROL
1,25-Dihydroxycholecalciferol
1,25-Dihydroxycholecaliferol
1,25-Dihydroxyvitamin D
1,25-Dihydroxyvitamin D3
1,25-dihydroxy vitamin D3
1,25-dihydroxy-20-epi-Vitamin D3
1,25-dihydroxycholecalciferol
1,25D3
1-alpha,-1,25-Dihydroxyvitamin D3
1-alpha,25-Dihydroxycholecalciferol
1-alpha,25-Dihydroxyvitamin D3
1-alpha-25-Dihydroxyvitamin D3
1-alpha-25-dihydroxyvitamin D3
1.Alpha.,25-Dihydroxy-26,27-hexadeuterovitamin D3
17936_FLUKA
17936_SIGMA
1a,25-(OH)2D3
1a,25-Dihydroxycholecalciferol
1a,25-Dihydroxyvitamin D3
1alpha,25(OH)2-D3
1alpha,25(OH)2D3
1alpha,25-Dihydroxycholecalciferol
1alpha,25-Dihydroxyvitamin D
1alpha,25-Dihydroxyvitamin D3
1db1
1α,25(OH)2D3
1α,25-dihydroxycholecalciferol
1α,25-dihydroxyvitamin D3
20-epi-1alpha,25-dihydroxycholecaliferol
25-Dihydroxycholecalciferol
32222-06-3
5-{2-[1-(5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha,3beta,25-triol
9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1.alpha.,3.beta,.5Z,7E)- & CD4
9,10-seco(5Z,7E)-5,7,10(19)-cholestatriene-1alpha, 3beta, 25-triol
AC-1859
AC1NQX1S
 
Ambap32222-06-3
Asentar
BCBcMAP01_000160
BML2-E03
BSPBio_001287
C01673
CCRIS 5522
CD-2027
CHEBI:17823
CHEMBL846
CID5280453
CPD000466393
Calcijex
Calcijex, Silkis, Rocaltrol, Topitriol, Cholecalciferol,Calcitriol
Calcitriol
Calcitriol (JAN/USAN/INN)
Calcitriol [USAN:INN:BAN:JAN]
Calcitriolum
Calcitriolum [INN-Latin]
D00129
D1530_SIGMA
DN 101
DN-101
Decostriol
Dihydroxyvitamin D3
EINECS 250-963-8
HMS1361A09
HMS1791A09
HMS1989A09
HMS2051F06
HMS2089N03
HSDB 3482
IDI1_033757
LMST03020258
LS-53093
MC-1288
MC1288
MLS000759536
MLS001424122
MolPort-002-045-698
NCGC00161327-01
NCGC00161327-04
Ro 21-5535
Ro 215535
Ro-21-5535
Rocaltrol
Rocaltrol (TN)
S1466_Selleck
SAM001246772
SMR000466393
Silkis
Soltriol
Spectrum5_002061
Topitriol
Toptriol
U 49562
Vectical
ZINC03924790
calcitriol
vit D
3PetrolatumPhase 484
4Trace ElementsPhase 43900
5vitamin dPhase 41524
6VitaminsPhase 43857
7MicronutrientsPhase 43901
8Vasoconstrictor AgentsPhase 41303
9Immunosuppressive AgentsPhase 410422
10Calcium, DietaryPhase 44678
11Calcineurin InhibitorsPhase 41223
12Dermatologic AgentsPhase 44555
13EmollientsPhase 4121
14Immunologic FactorsPhase 418483
15Bone Density Conservation AgentsPhase 42600

Interventional clinical trials:

idNameStatusNCT IDPhase
1Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis AlbaCompletedNCT01388517Phase 4

Search NIH Clinical Center for Pityriasis Rosea

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: pityriasis rosea

Genetic Tests for Pityriasis Rosea

About this section

Anatomical Context for Pityriasis Rosea

About this section

MalaCards organs/tissues related to Pityriasis Rosea:

33
Skin, Heart, Prostate, Bone, Endothelial, B cells, Lung

Animal Models for Pityriasis Rosea or affiliated genes

About this section

MGI Mouse Phenotypes related to Pityriasis Rosea:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes

Publications for Pityriasis Rosea

About this section

Articles related to Pityriasis Rosea:

(show top 50)    (show all 391)
idTitleAuthorsYear
1
Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. (27212277)
2016
2
Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability. (26009712)
2015
3
The diagnostic criteria of pityriasis rosea and Gianotti-Crosti syndrome - a protocol to establish diagnostic criteria of skin diseases. (26517103)
2015
4
Pityriasis rosea-like adverse reaction to atenolol. (25791321)
2015
5
Multiple recurrences in pityriasis rosea - a case report with review of the literature. (24891682)
2014
6
The prevalence of herpes zoster and pityriasis rosea in patients with psoriasis: a preliminary study. (25353629)
2014
7
Polymorphic pityriasis rosea precipitating psoriasis. (23437430)
2013
8
Palmar herald patch in pityriasis rosea. (22881477)
2012
9
Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients. (20477925)
2011
10
The pityriasis rosea calendar: a 7 year review of seasonal variation, age and sex distribution. (20450028)
2010
11
Pityriasis rosea in a woman and her husband - case report and review of the literature. (21399750)
2010
12
Childhood Pityriasis rosea inversa without Herald Patch Mimicking Cutaneous Mastocytosis. (23056712)
2010
13
Childhood pityriasis rosea. (20199459)
2009
14
Atypical Pityriasis rosea in a black child: a case report. (20181179)
2009
15
Pregnancy outcome in patients with pityriasis rosea. (18489054)
2008
16
Pityriasis rosea. (18297832)
2008
17
Pityriasis rosea occurring during acyclovir therapy. (17558061)
2007
18
Pityriasis rosea. (16948385)
2006
19
Macular eruption. Pityriasis rosea. (17044638)
2006
20
The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea. (17062081)
2006
21
Diseases of the epidermis: pityriasis rosea, lichen planus, keratosis pilaris. (16463931)
2005
22
Is human herpesvirus 7 the causative agent of pityriasis rosea?--A critical review. (15569005)
2004
23
Avidity of antibodies to human herpesvirus 7 suggests primary infection in young adults with pityriasis rosea. (15482314)
2004
24
Pityriasis rosea unilateralis. (17642826)
2003
25
Rash orientation in pityriasis rosea: a qualitative study. (11978566)
2002
26
Human herpes virus-like particles in pityriasis rosea lesions: an electron microscopy study. (12135467)
2002
27
Pityriasis rosea associated with herpesvirus 7 DNA. (11204526)
2000
28
Peripheral T-lymphocyte count in pityriasis rosea. (20921775)
1998
29
Human herpesvirus 7 in pityriasis rosea. (9149704)
1997
30
A pityriasis rosea-like eruption secondary to bacillus Calmette-GuAcrin therapy for bladder cancer. (8804852)
1996
31
Recurrent pityriasis rosea. New episodes every year for five years. A case report. (1969211)
1990
32
An epidemiological study of pityriasis rosea in Middle Road Hospital. (2595391)
1989
33
Meyerson's naevi in pityriasis rosea. (2923801)
1989
34
Treatment of pityriasis rosea with UV radiation. (6847217)
1983
35
Recent upper respiratory tract infection and pityriasis rosea: a case-control study of 249 matched pairs. (6849825)
1983
36
Pityriasis rosea (Herald spot). (753853)
1977
37
Cytolytic degeneration of keratinocytes adjacent to Langerhans cells in pityriasis rosea (Gibert). (58531)
1976
38
Pityriasis rosea. (5791923)
1969
39
Pityriasis rosea. (5366150)
1969
40
Pityriasis rosea. (4169075)
1968
41
PITYRIASIS ROSEA, WITH SPECIAL EMPHASIS IN CHILDREN. (14045147)
1963
42
Does the tanned skin prevent eruption of pityriasis rosea? (13443506)
1957
43
Pityriasis rosea. (13370205)
1956
44
The nature of pityriasis rosea. [Hebrew text; English summary]. (14860657)
1951
45
Coincidence of pityriasis rosea with pregnancy. (14770492)
1950
46
Pityriasis Rosea with Unusual Distribution. (19979906)
1917
47
Discussion on Pityriasis Rosea. (19977612)
1914
48
Discussion on Pityriasis Rosea. (19977610)
1914
49
50

Variations for Pityriasis Rosea

About this section

Expression for genes affiliated with Pityriasis Rosea

About this section
Search GEO for disease gene expression data for Pityriasis Rosea.

Pathways for genes affiliated with Pityriasis Rosea

About this section

Pathways related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show top 31)    (show all 32)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.0HLA-A, HLA-B, HLA-C
29.0HLA-A, HLA-B, HLA-C
39.0HLA-A, HLA-B, HLA-C
49.0HLA-A, HLA-B, HLA-C
59.0HLA-A, HLA-B, HLA-C
6
Show member pathways
9.0HLA-A, HLA-B, HLA-C
78.6HLA-DRB1, HLA-DRB4, HLA-DRB5
8
Show member pathways
8.5HLA-A, HLA-C, HLA-DQB1, HLA-DRB5
9
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
10
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
11
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
12
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
13
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
14
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
15
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
168.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
178.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
188.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
198.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
208.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
21
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
22
Show member pathways
8.2HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
236.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
246.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
256.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
26
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
27
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
286.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
29
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
30
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4
31
Show member pathways
6.7HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4

GO Terms for genes affiliated with Pityriasis Rosea

About this section

Cellular components related to Pityriasis Rosea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:00426139.8HLA-DQB1, HLA-DRB4
2integral component of lumenal side of endoplasmic reticulum membraneGO:00715569.3HLA-C, HLA-DQB1, HLA-DRB4
3cell surfaceGO:00099869.0HLA-A, HLA-B, HLA-C
4external side of plasma membraneGO:00098978.6HLA-DRB1, HLA-DRB4, HLA-DRB5
5trans-Golgi network membraneGO:00325888.1HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
6ER to Golgi transport vesicle membraneGO:00125077.9HLA-A, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB4

Biological processes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1protection from natural killer cell mediated cytotoxicityGO:004227010.0HLA-A, HLA-B
2positive regulation of T cell mediated cytotoxicityGO:000191610.0HLA-A, HLA-B
3peptide antigen assembly with MHC class II protein complexGO:00025039.8HLA-DRB1, HLA-DRB4
4negative regulation of T cell proliferationGO:00421309.7HLA-DRB4, HLA-DRB5
5humoral immune response mediated by circulating immunoglobulinGO:00024559.6HLA-DRB1, HLA-DRB4
6antigen processing and presentation of peptide antigen via MHC class IGO:00024749.4HLA-A, HLA-B, HLA-C
7regulation of interleukin-10 secretionGO:20011799.3HLA-DRB1, HLA-DRB4, HLA-DRB5
8T-helper 1 type immune responseGO:00420889.2HLA-DRB1, HLA-DRB4, HLA-DRB5
9viral processGO:00160329.0HLA-A, HLA-B, HLA-C
10immunoglobulin production involved in immunoglobulin mediated immune responseGO:00023818.8HLA-DQB1, HLA-DRB1, HLA-DRB4, HLA-DRB5
11immune responseGO:00069558.6HLA-DRB1, HLA-DRB4, HLA-DRB5
12interferon-gamma-mediated signaling pathwayGO:00603338.5HLA-A, HLA-B, HLA-C, HLA-DRB4
13antigen processing and presentationGO:00198828.0HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DRB1, HLA-DRB5

Molecular functions related to Pityriasis Rosea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide antigen bindingGO:00426058.6HLA-A, HLA-B, HLA-DRB4

Sources for Pityriasis Rosea

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet